1Baer FM ,Voth E, Schneider CA, et al. Comparison of low - dosedobu- tamine- gradient- echo magnetic resonance imaging and positron emission tomography with 18F -fluorodeoxygiucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability[ J]. Circulation,1995,91(4) :1006 -1015.
3Ernst Wellnhofer, Adriana Olariu, Christoph Klein, et aL Magnetic resonance low - dose dobutamine test is superior to scar quantification for the prediction of functional recovery [ J ]. Circulation 2004, 109, 2172 - 2174.
5Jaeksona E, Bellengerb N, Secldonb M, et al. Ischaemic and non - isehaemic cardiomyopathiesd cardiac MRI appearances with delayed enhancement[J]. Clin Radiol, 2007, 62(5) :395 -403.
6Kwong RY, Chan AK, Brown K, et al. Impact of unrecognised myo- cardial scar detected by cardial magnetic resonance imaging on eventfree survival in patients presenting with signs or symptoms of coro- nary artery disease[J], circulation, 2006,113(23) :2733 -2743.
7Hillenbrand HB,Kim R J, Parker MA,et al. Early assessment of myo- cardial salvage by contrast - enhanced magnetic resonance imaging [ J]. Circulation ,2000,102(14) : 1678 - 1683.
8Kim ILl, Wu E, Rafael A, et al: The use of contrast -enhanced magnetic resonance imaging to identify reversible myocardial dysfunction[J]. N Engl J Med,2000,343:1445 - 1453.
9Beer M,Machann W, Sandstede J,et al. Energetic difference between visable and non - viable myocardium in patients with recent myocardi- al infarction are not an effect of differences in wall thinning a mutivox- el 31P - MR - spectroscopy and MRI study[ J ]. Eur Radol,2007,17 (5) :1275 - 1283.
10Horn M, Weidensteiner C, Scheffer H, et al. Detection of myocardial viability based on measurement of sodium eontent:a (23)Na- NMR study[ J ]. Magn Reson Med,200 1,45 (5) :756 - 764.
4Baer FM, Theissen P, Crnac J, et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular function recovery in patients with chronic coronary artery disease [J]. Eur Heart J, 2000,21(12):981-991.
5Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for health care professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J]. Circulation, 2002,105(4):539-542.
6Zamorano J, Delgado J, Almeria C, et al. Reason for discrepancies in identifying myocardial viability by thallium-201 redistribution, magnetic resonance imaging, and dobutamine echocardiography [J]. Am J Cardiol, 2002,90(5):455-459.
7Nelson C, McCrohon J, Khafagi F, et al. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging [J]. J Am Coll Cardiol, 2004,43(7):1248-1256.
8Baumgartner H, Porenta G, Lau YK, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts [J]. J Am Coll Cardiol, 1998,32(6): 1701-1708.
9Schwitter J,Nanz D,Kneifel S,et al.Assessment of myocardial perfusion in coronary artery disease by magnetic resonance:a comparison with positron emission tomography and coronary angiography[J].Circulation,2001,103(18):2230-2235.
10Cerqueira MD,Weissman NJ,Dilsizian V,et al.Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart:a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association[J].Circulation,2002,105(4):539-542.
3Schelbert EB,Cao J J,Sigurdsson S,et al.Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults[J].JAMA,2012,308 (9):890-896.
4Yoon YE,Kitagawa K,Kato S,et al.Prognostic significance of unrecognized myocardial infarction detected with MR imaging in patients with impaired fasting glucose compared with those with diabetes[J].Radiology,2012,262(3):807-815.
5Maradit-Kremers H,Crowson CS,Nicola PJ,et al.Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis:a populationbased cohort study[J].Arthritis Rheum,2005,52 (2):402-411.
6Pride YB,Piccirillo BJ,Gibson CM.Prevalence,consequences,and implications for clinical trials of unrecognized myocardial infarction[J].Am J Cardiol,2013,111(6):914-918.
7Boland LL,Folsom AR,Sorlie PD,et al.Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years the ARIC study[J].Am J Cardiol,2002,90(9):927-931.
8Torbal A,Boersma E,Kors JA,et al.Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older:the Rotterdam Study[J].Eur Heart J,2006,27:729-736.
9Levitan EB,Safford MM,Kilgore ML,et al.Assessment tools for unrecognized myocardial infarction:a cross-sectional analysis of the Reasons for Geographic and Racial Differences in Stroke population[J].BMC Cardiovasc Disord,2013,13(1):1-8.
10Krijthe BP,Leening MJG,Heeringa J,et al.Unrecognized myocardial infarction and risk of atrial fibrillation:The Rotterdam Study[J].Int J Cardiol,2013,30:1453-1457.
